🇺🇸 FDA

Company profile · Sponsor

CG

CG Oncology

CGON · NYSE biotech DALLAS, TX, USA
Pipeline
8
Drugs
0
Patents
5

Quick answer

CG (CGON) is a biotech company. headquartered in DALLAS, TX, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 5 patents to this profile..

Company facts

Ticker CGON
Exchange NYSE
Company type biotech
Headquarters DALLAS, TX, USA
SEC CIK 0001991792

Pipeline (8)

Search pipeline →

  1. CG0070 Adenovirus Vector

    CG

    Transitional Cell Carcinoma

    phase 3 mab terminated

    1 trial

  2. Cretostimogene Grenadenorepvec

    CG

    Non Muscle Invasive Bladder Cancer

    phase 3 mab active

    2 trials

  3. CG0070

    CG

    Bladder Cancer

    phase 2 mab completed

    1 trial

  4. CG0070

    CG

    Non Muscle Invasive Bladder Cancer

    phase 2 mab completed

    1 trial

  5. Cretostimogene Grenadenorepvec

    CG

    High-Risk Non-Muscle-Invasive Bladder Cancer

    phase 2 small molecule active

    1 trial

  6. Ivaltinostat

    CG

    Metastatic Pancreatic Adenocarcinoma

    phase 2 small molecule active

    1 trial

  7. oncolytic adenovirus expressing GMCSF

    CG

    Bladder Cancer

    phase 2 mab terminated

    1 trial

  8. CG0070

    CG

    Muscle-Invasive Bladder Carcinoma

    phase 1 small molecule completed

    1 trial

Patents (5)

Search patents →

  1. US 12370229

    Methods of treating bladder cancer

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12090183

    Methods of treating solid or lymphatic tumors by combination therapy

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11596660

    Methods of treating bladder cancer

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11497781

    Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11338003

    Methods of treating bladder cancer with an oncolytic virus

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is CG?

CG (CGON) is a biotech company. headquartered in DALLAS, TX, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 5 patents to this profile..

What pipeline programs does CG sponsor?

We track 8 ClinicalTrials.gov-linked programs for CG, including CG0070 Adenovirus Vector and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does CG company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.